Clinical Trials Browser

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT03431311 2019-06-13

TCR-CRC-001

Phase 1/2 Terminated

1 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03013712 2017-01-06

CARTEPC

Phase 1/2 Unknown

60 enrolled

GastrointestinalGenitourinary

Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT02959151 2016-11-08

A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy

Phase 1/2 Unknown

20 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

Clinical Trials

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients

ResCPa

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers

SBRT Plus vNKT for Pancreatic Cancer

NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

CAR-T Cell Immunotherapy for HCC Targeting GPC3

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

TCR-CRC-001

CARTEPC

A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy